The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Hepatic Microcirculation in Fatty Liver Disease
Abstract
Nonalcoholic fatty liver disease (NAFLD), the most common cause of steatosis, is associated with visceral obesity and insulin resistance. With more severe risk factors (obesity, type 2 diabetes [T2D], metabolic syndrome), steatosis may be complicated by hepatocellular injury and liver inflammation (steatohepatitis or NASH). NASH can lead to perisinusoidal fibrosis and cirrhosis. Fat‐laden hepatocytes are swollen, and in steatohepatitis, further swelling occurs due to hydropic change (ballooning) of hepatocytes to cause sinusoidal distortion, as visualized by in vivo microscopy, reducing intrasinusoidal volume and microvascular blood flow. Involvement of other cell types (sinusoidal endothelial cells, Kupffer cells, stellate cells) and recruitment of inflammatory cells and platelets lead to dysregulation of microvascular blood flow. In animal models, the net effect of such changes is a marked reduction of sinusoidal space (∼50% of control), and a decrease in the number of normally perfused sinusoids. Such microvascular damage could accentuate further liver injury and disease progression in NASH. The fatty liver is also exquisitely sensitive to ischemia‐reperfusion injury, at least partly due to the propensity of unsaturated fatty acids to undergo lipid peroxidation in the face of reactive oxygen species (ROS). This has important clinical consequences, particularly limiting the use of fatty donor livers for transplantation. In this review, we discuss available data about the effects of steatosis and steatohepatitis on the hepatic microvascular structure and sinusoidal blood flow, highlighting areas for future investigation. Anat Rec, 291:684–692, 2008. © 2008 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
Farrell, G. C., & Larter, C. Z. (2006) · Hepatology · doi:10.1002/hep.20973 · Cited by 2,414
Self-citationThe Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease
Hamaguchi, M., Kojima, T., Takeda, N., Nakagawa, T., Taniguchi, H., Fujii, K., Omatsu, T., Nakajima, T., Sarui, H., Shimazaki, M., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-10-200511150-00009 · Cited by 1,062
RISK FACTORS FOR PRIMARY DYSFUNCTION AFTER LIVER TRANSPLANTATION—A MULTIVARIATE ANALYSIS
PLOEG, R. J., DʼALESSANDRO, A. M., KNECHTLE, S. J., STEGALL, M. D., PIRSCH, J. D., HOFFMANN, R. M., SASAKI, T., SOLLINGER, H. W., BELZER, F. O., & KALAYOGLU, M. (1993) · Transplantation · doi:10.1097/00007890-199304000-00024 · Cited by 1,026
Yang, S. Q., Lin, H. Z., Lane, M. D., Clemens, M., & Diehl, A. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2557 · Cited by 810
CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis
Leclercq, I. A., Farrell, G. C., Field, J., Bell, D. R., Gonzalez, F. J., & Robertson, G. R. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8814 · Cited by 764
Self-citationInsulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression
Hui, J. M., Sud, A., Farrell, G. C., Bandara, P., Byth, K., Kench, J. G., McCaughan, G. W., & George, J. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.08.032 · Cited by 718
Self-citationThe utility of marginal donors in liver transplantation
Busuttil, R. W., & Tanaka, K. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50105 · Cited by 662
Etiopathogenesis of Nonalcoholic Steatohepatitis
Chitturi, S., & Farrell, G. C. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12927 · Cited by 661
Self-citationFarrell, G. C., Chitturi, S., Lau, G. K., Sollano, J. D., & NAFLD, F. T. A. W. P. O. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05002.x · Cited by 517
Self-citationKoteish, A., & Diehl, A. M. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12932 · Cited by 445
Fatty Liver in Liver Transplantation and Surgery
Selzner, M., & Clavien, P.-A. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12933 · Cited by 429
JNK1 but not JNK2 promotes the development of steatohepatitis in mice
Schattenberg, J. M., Singh, R., Wang, Y., Lefkowitch, J. H., Rigoli, R. M., Scherer, P. E., & Czaja, M. J. (2006) · Hepatology · doi:10.1002/hep.20999 · Cited by 384 · cited 1×
“…used to establish molecular pathways of inflammatory recruitment and liver injury in steatohepatitis (Leclercq et al., 2000, 2004; Ip et al., 2004; McCuskey et al., 2004; de la Peña et al., 2005, 2007; Schattenberg et al., 2005, 2006), and in ischemia– reperfusion injury (Baskin-Bey et al., 2005).”
MethodIp, E., Farrell, G., Hall, P., Robertson, G., & Leclercq, I. (2004) · Hepatology · doi:10.1002/hep.20170 · Cited by 383
Self-citationSteatosis: Co-factor in Other Liver Diseases *
Powell, E. E., Jonsson, J. R., & Clouston, A. D. (2005) · Hepatology · doi:10.1002/hep.20750 · Cited by 374
PRIMARY NONFUNCTION OF HEPATIC ALLOGRAFTS WITH PREEXISTING FATTY INFILTRATION1
TODO, S., DEMETRIS, A. J., MAKOWKA, L., TEPERMAN, L., PODESTA, L., SHAVER, T., TZAKIS, A., & STARZL, T. E. (1989) · Transplantation · doi:10.1097/00007890-198905000-00034 · Cited by 353
Zhang, F., Ram, J. L., Standley, P. R., & Sowers, J. R. (1994) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1994.266.4.c975 · Cited by 348
Chitturi, S., Farrell, G. C., Hashimoto, E., Saibara, T., Lau, G. K., Sollano, J. D., & NAFLD, T. A. W. P. O. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05001.x · Cited by 312
Self-citationEndothelin-1 induces direct constriction of hepatic sinusoids
Zhang, J. X., Pegoli, W., & Clemens, M. G. (1994) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1994.266.4.g624 · Cited by 298
Mechanisms of Ischemic Injury Are Different in the Steatotic and Normal Rat Liver
Selzner, M., RüDiger, H. A., Sindram, D., Madden, J., & Clavien, P.-A. (2000) · Hepatology · doi:10.1053/jhep.2000.20528 · Cited by 288
dela Peña, A., Leclercq, I., Field, J., George, J., Jones, B., & Farrell, G. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.09.004 · Cited by 287
Self-citationBody mass index as a predictor of hepatic steatosis in living liver donors
Rinella, M. E., Alonso, E., Rao, S., Whitington, P., Fryer, J., Abecassis, M., Superina, R., Flamm, S. L., & Blei, A. T. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.23787 · Cited by 259
Verran, D., Kusyk, T., Painter, D., Fisher, J., Koorey, D., Strasser, S., Stewart, G., & McCaughan, G. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50099 · Cited by 259
Rizki, G., Arnaboldi, L., Gabrielli, B., Yan, J., Lee, G. S., Ng, R. K., Turner, S. M., Badger, T. M., Pitas, R. E., & Maher, J. J. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600198-jlr200 · Cited by 258
Cameron, A. M., Ghobrial, R. M., Yersiz, H., Farmer, D. G., Lipshutz, G. S., Gordon, S. A., Zimmerman, M., Hong, J., Collins, T. E., Gornbein, J., et al. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000219669.84192.b3 · Cited by 257
THE USE OF mARGINAL DONORS FOR LIVER TRANSPLANTATION A RETROSPECTIVE STUDY OF 365 LIVER DONORS 1,2
MOR, E., KLINTMALM, G. B., GIBBS, J. F., WATEMBERG, I., GOLDSTEIN, R. M., & HUSBERG, B. S. (1992) · Transplantation · doi:10.1097/00007890-199202010-00022 · Cited by 237
Curcumin inhibits NF-κB activation and reduces the severity of experimental steatohepatitis in mice
Leclercq, I. A., Farrell, G. C., Sempoux, C., Peña, A. D., & Horsmans, Y. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.08.010 · Cited by 224
Self-citationSteatohepatitis Induced by Intragastric Overfeeding in Mice *
Deng, Q.-G., She, H., Cheng, J. H., French, S. W., Koop, D. R., Xiong, S., & Tsukamoto, H. (2005) · Hepatology · doi:10.1002/hep.20877 · Cited by 215
Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice
McCuskey, R. S., Ito, Y., Robertson, G. R., McCuskey, M. K., Perry, M., & Farrell, G. C. (2004) · Hepatology · doi:10.1002/hep.20302 · Cited by 210
Self-citationHepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling
Schattenberg, J. M., Wang, Y., Singh, R., Rigoli, R. M., & Czaja, M. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410310200 · Cited by 194 · cited 1×
“…used to establish molecular pathways of inflammatory recruitment and liver injury in steatohepatitis (Leclercq et al., 2000, 2004; Ip et al., 2004; McCuskey et al., 2004; de la Peña et al., 2005, 2007; Schattenberg et al., 2005, 2006), and in ischemia– reperfusion injury (Baskin-Bey et al., 2005).”
MethodImpairment of Hepatic Microcirculation in Fatty Liver
IJAZ, S., YANG, W., WINSLET, M. C., & SEIFALIAN, A. M. (2003) · Microcirculation · doi:10.1038/sj.mn.7800206 · Cited by 192
Fatty liver and the metabolic syndrome among Shanghai adults
FAN, J., ZHU, J., LI, X., CHEN, L., LU, Y., LI, L., DAI, F., LI, F., & CHEN, S. (2005) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2005.04058.x · Cited by 186
Genotype‐specific mechanisms for hepatic steatosis in chronic hepatitis C infection
Hui, J. M., Kench, J., Farrell, G. C., Lin, R., Samarasinghe, D., Liddle, C., Byth, K., & George, J. (2002) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2002.02813.x · Cited by 178
Self-citationAnimal models of steatohepatitis
Koteish, A., & Mae Diehl, A. (2002) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2002.0332 · Cited by 175
THE EFFECT OF GRADED STEATOSIS ON FLOW IN THE HEPATIC PARENCHYMAL MICROCIRCULATION1,2
Seifalian, A. M., Piasecki, C., Agarwal, A., & Davidson, B. R. (1999) · Transplantation · doi:10.1097/00007890-199909270-00009 · Cited by 168
Arsov, T., Silva, D. G., O’Bryan, M. K., Sainsbury, A., Lee, N. J., Kennedy, C., Manji, S. S. M., Nelms, K., Liu, C., Vinuesa, C. G., et al. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0494 · Cited by 166
Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?
Larter, C. Z., & Farrell, G. C. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.11.030 · Cited by 155
Self-citationIn vivo demonstration of impaired microcirculation in steatotic human liver grafts
Seifalian, A. M., Chidambaram, V., Rolles, K., et al. (1998) · Liver Transplantation and Surgery · doi:10.1002/lt.500040110 · Cited by 146
Diabetes duration and cause-specific mortality in the Verona Diabetes Study.
Brun, E., Nelson, R. G., Bennett, P. H., Imperatore, G., Zoppini, G., Verlato, G., Muggeo, M., & Study, V. D. (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1119 · Cited by 135
Adaptive failure to high-fat diet characterizes steatohepatitis in Alms1 mutant mice
Arsov, T., Larter, C. Z., Nolan, C. J., Petrovsky, N., Goodnow, C. C., Teoh, N., Yeh, M. M., & Farrell, G. C. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.02.032 · Cited by 119
Self-citationThe use of donor fatty liver for liver transplantation: a challenge or a quagmire?
Trevisani, F., Colantoni, A., Caraceni, P., et al. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80195-4 · Cited by 102
Baskin-Bey, E. S., Canbay, A. E., Bronk, S. F., Werneburg, N. W., Guicciardi, M. E., Nyberg, S. L., & Gores, G. J. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00316.2004 · Cited by 94
The effect of donor weight reduction on hepatic steatosis for living donor liver transplantation
Hwang, S., Lee, S., Jang, S.-J., Cho, S.-H., Kim, K., Ahn, C., Moon, D., & Ha, T. (2004) · Liver Transplantation · doi:10.1002/lt.20172 · Cited by 93
Bauer, M. W., Paquette, N. C., Zhang, J. X., Bauer, I., Pannen, B. H. J., Kleeberger, S. R., & Clemens, M. G. (1995) · Hepatology · doi:10.1002/hep.1840220533 · Cited by 86
Teoh, N., Ito, Y., Field, J., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.027 · Cited by 69
Self-citationHasegawa, T., Ito, Y., Wijeweera, J., Liu, J., Malle, E., Farhood, A. I., McCuskey, R. S., & Jaeschke, H. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00246.2006 · Cited by 69
Self-citationFatty Liver Disease; NASH and Related Disorders
Charlton, M. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.09.050 · Cited by 68
ASSESSMENT OF DONOR FATTY LIVERS FOR LIVER TRANSPLANTATION1
Cheng, Y., Chen, C. L., Lai, C.-Y., et al. (2001) · Transplantation · doi:10.1097/00007890-200105150-00007 · Cited by 67
Sinusoidal Flow Block after Warm Ischemia in Rats with Diet-Induced Fatty Liver
Hakamada, K., Sasaki, M., Takahashi, K., Umehara, Y., & Konn, M. (1997) · Journal of Surgical Research · doi:10.1006/jsre.1997.5077 · Cited by 67
Nonalcoholic Steatohepatitis in Donors for Living Donor Liver Transplantation
Yamamoto, K., Takada, Y., Fujimoto, Y., Haga, H., Oike, F., Kobayashi, N., & Tanaka, K. (2007) · Transplantation · doi:10.1097/01.tp.0000250671.06456.3f · Cited by 65
Recurrence of autoimmune hepatitis after liver transplantation
Götz, G., Neuhaus, R., Bechstein, W. O., et al. (1999) · Transplantation Proceedings · doi:10.1016/s0041-1345(98)01692-3 · Cited by 62
Fatty liver now, diabetes and heart attack later? The liver as a barometer of metabolic health
Chitturi, S., & Farrell, G. C. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04995.x · Cited by 50
Self-citationDietary Steatotic Liver Attenuates Acetaminophen Hepatotoxicity in Mice
Ito, Y., Abril, E. R., Bethea, N. W., McCuskey, M. K., & McCuskey, R. S. (2006) · Microcirculation · doi:10.1080/10739680500383423 · Cited by 49
Self-citationPeňa, A. D., Leclercq, I. A., Williams, J., & Farrell, G. C. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.08.025 · Cited by 49
Self-citationRole of endotoxin in the hepatic microvascular inflammatory response to ethanol
McCuskey, R. S., Nishida, J., EGUCHI, H., McDonnell, D., BAKER, G., Ekataksin, W., KRASOVICH, M., Rudi, V., Seitz, H., Urbaschek, B., et al. (1995) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1995.tb01790.x · Cited by 45
Self-citationBAUER, M. (1995) · Hepatology · doi:10.1016/0270-9139(95)90166-3 · Cited by 27
Cited by
Inflammasome activation and function in liver disease
Szabo, G., & Petrasek, J. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.94 · Cited by 597
Francque, S. M., van der Graaff, D., & Kwanten, W. J. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.005 · Cited by 556
Vollmar, B., & Menger, M. D. (2009) · Physiological Reviews · doi:10.1152/physrev.00027.2008 · Cited by 500
Spatial heterogeneity in the mammalian liver
Ben-Moshe, S., & Itzkovitz, S. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0134-x · Cited by 485
Kupffer cells in non-alcoholic fatty liver disease: The emerging view
Baffy, G. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.03.008 · Cited by 473
Metadata
- Authors
- Farrell, G. C., Teoh, N. C., & Mccuskey, R. S.
- Venue
- The Anatomical Record
- Publisher
- Wiley
- Published
- 2008-05-16
- Volume
- 291
- Issue
- 6
- Pages
- 684-692
- ISSN
- 1932-8486 (ISSN-L)
- 1932-8494
- OpenAlex
- W2072759932
- Cited by
- 266
- References
- 58
- FWCI
- 10.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.